• Home
  •  / Rivus Pharmaceuticals

Rivus Pharmaceuticals

  • Total Funding$35 M

OverviewSuggest Edit

Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health. It focuses on promoting a new therapeutic approach that uses the body's natural metabolic processes to improve cellular metabolism and reverse the course of disease. The company aims to eliminate the major metabolic risk factors for cardiovascular mortality and morbidity by developing controlled metabolic accelerators (CMAs).
TypePrivate
Founded2019
HQCharlottesville, VA, USMap
Websiterivuspharma.com
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Aug 2022)4
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Rivus Pharmaceuticals

Shaharyar Khan

Shaharyar Khan

Chief Scientific Officer
Francisco Portell

Francisco Portell

VP, Pharmaceutical Development
Allen Cunningham

Allen Cunningham

Chief Executive Officer
Show more

Rivus Pharmaceuticals Office Locations

Rivus Pharmaceuticals has an office in Charlottesville
Charlottesville, VA, US (HQ)
706 Forest St b
Show all (1)

Rivus Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

2019

Rivus Pharmaceuticals total Funding

$35 m

Rivus Pharmaceuticals latest funding size

$35 m

Time since last funding

a year ago

Rivus Pharmaceuticals investors

Longitude Capital, Medicxi Ventures, RxCapital
Rivus Pharmaceuticals's latest funding round in July 2021 was reported to be $35 m. In total, Rivus Pharmaceuticals has raised $35 m
Show all financial metrics

Rivus Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

Learn more about our premium products
SecurityScorecard logo

Rivus Pharmaceuticals Online and Social Media Presence

Rivus Pharmaceuticals's Trends

Embed Graph

Rivus Pharmaceuticals News and Updates

February 09, 2022

Rivus Pharmaceuticals Announces Positive Data from Phase 2a Clinical Trial of Lead Candidate HU6, Demonstrating Fat Reduction and Weight Loss in High BMI Participants

CHARLOTTESVILLE, Va., Feb. 9, 2022 /PRNewswire/ -- Rivus Pharmaceuticals Inc., a biopharmaceutical company dedicated to improving cardio-metabolic health, today announced positive results from a Phase 2a clinical trial of HU6 in obese participants with elevated liver fat. In eight weeks,...
July 22, 2021

Rivus Pharmaceuticals Raises $35M in Series A Financing

Rivus Pharmaceuticals, Inc., a Charlottesville, Va.-based biopharmaceutical company dedicated to improving cardio-metabolic health, closed a $35m Series A financing

 Rivus Pharmaceuticals Frequently Asked Questions

  • When was Rivus Pharmaceuticals founded?

    Rivus Pharmaceuticals was founded in 2019.

  • Who are Rivus Pharmaceuticals key executives?

    Rivus Pharmaceuticals's key executives are Shaharyar Khan, Francisco Portell and Allen Cunningham.

  • How many employees does Rivus Pharmaceuticals have?

    Rivus Pharmaceuticals has 4 employees.

  • Who are Rivus Pharmaceuticals competitors?

    Competitors of Rivus Pharmaceuticals include DCC Vital, SAI MedPartners and OptiNose.

  • Where is Rivus Pharmaceuticals headquarters?

    Rivus Pharmaceuticals headquarters is located at 706 Forest St b, Charlottesville.

  • Where are Rivus Pharmaceuticals offices?

    Rivus Pharmaceuticals has an office in Charlottesville.

  • How many offices does Rivus Pharmaceuticals have?

    Rivus Pharmaceuticals has 1 office.